NGL Fine-Chem Ltd.
Fundamentals
- Market cap
- ₹1,847 cr
- P/E
- 38.38×
- ROE
- 7.39%
- Debt / equity
- 0.27
- Div yield
- 0.06%
- 52-week range
- 1006.00 — 3232.00
Company snapshot
NGL Fine-Chem Ltd.
Pharmaceuticals
₹1,668 cr
P/E 34.67×
Latest quarter · Mar 2026
Sales₹149 cr
Net profit₹13 cr
Op. margin+14.3%
EPS₹21.83
Strength & growth
Debt / equity0.27×
Current ratio1.98×
Sales CAGR+17.9%
EPS CAGR+15.1%
The timeline — 5 notes on NGL Fine-Chem Ltd.
May 2026
- 22 May 26 · 10:54 AM IST Brief Brief · Earnings · Small cap
NGL Fine-Chem profit jumps 128% as India revenue more than doubles
Consolidated net profit surged to ₹48.13 crore in FY26, outpacing a 36% rise in revenue to ₹500.95 crore on broad-based demand.
- 22 May 26 · 10:53 AM IST Brief Brief · Earnings · Small cap
NGL Fine-Chem profit more than doubles to ₹48 cr on broad-based demand
Consolidated revenue rose 36% for the full year, with domestic sales more than doubling and rest-of-world surging 78%.
- 21 May 26 · 9:41 PM IST Brief Brief · Earnings · Small cap
NGL Fine-Chem profit jumps 128% on strong domestic and export demand
Consolidated revenue rose 36% to ₹500.95 crore, while India sales more than doubled, lifting net profit to ₹48.13 crore.
- 21 May 26 · 9:25 PM IST Brief Brief · Earnings · Small cap
NGL Fine-Chem profit surges 128% on broad geographic growth
Consolidated revenue rose 36% to ₹500.95 cr, but net profit jumped 128% to ₹48.13 cr, signalling strong cost control as India and rest-of-world sales surged.
- 21 May 26 · 9:21 PM IST Brief Brief · Earnings · Small cap
NGL Fine-Chem profit surges 128% as Indian revenue doubles
Consolidated profit jumped to ₹48.13 crore on 36% revenue growth, driven by a more-than-doubling of Indian operations.